Hualan Biological Engineering Inc.
002007
Kedudukan dalam Saham
#4386
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Harga Saham
$1.92
Modal Pasaran
$3.50B
Perubahan (1 hari)
-1.39%
Perubahan (1 tahun)
-19.45%
Negara
CN
Perdagangan Hualan Biological Engineering Inc. (002007)
Kategori
Healthcare
Margin Operasi untuk Hualan Biological Engineering Inc. (002007)
Margin Operasi pada October 2026 TTM: 21.31%
Menurut laporan kewangan dan harga saham terkini Hualan Biological Engineering Inc., margin operasi semasa (TTM) ialah 21.31%. Pada akhir 2024, margin operasi syarikat ialah 31.50%.
Sejarah Margin Operasi untuk Hualan Biological Engineering Inc. dari 2001 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | 21.31% | -13.65% |
| 2025 | 24.68% | -21.65% |
| 2024 | 31.50% | -19.81% |
| 2023 | 39.28% | 24.54% |
| 2022 | 31.54% | -17.52% |
| 2021 | 38.24% | -10.68% |
| 2020 | 42.81% | -1.92% |
| 2019 | 43.65% | 0.92% |
| 2018 | 43.25% | 11.81% |
| 2017 | 38.68% | -10.67% |
| 2016 | 43.30% | -4.65% |
| 2015 | 45.41% | -3.26% |
| 2014 | 46.94% | -2.49% |
| 2013 | 48.14% | 55.54% |
| 2012 | 30.95% | -35.41% |
| 2011 | 47.92% | -24.42% |
| 2010 | 63.40% | -2.27% |
| 2009 | 64.87% | 39.09% |
| 2008 | 46.64% | 30.24% |
| 2007 | 35.81% | 33.67% |
| 2006 | 26.79% | 61.78% |
| 2005 | 16.56% | 3.50% |
| 2004 | 16.00% | -4.59% |
| 2003 | 16.77% | -14.87% |
| 2002 | 19.70% | 33.47% |
| 2001 | 14.76% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -98.19% |
US
|
|
| -149.01% | -106.99% |
US
|
|
| 25.57% | -98.80% |
AU
|
|
| 28.81% | -98.65% |
NL
|
|
| 31.23% | -98.53% |
BE
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.